Immatics (IMTX) Leases (2019 - 2025)
Immatics recorded quarterly Leases of $14.9 million in Q4 2025, down 7.11% quarter-over-quarter from $16.0 million in Q3 2025, and up 4.47% year-over-year from $14.2 million in Q4 2024.
Immatics' Leases history runs 7 years deep, the most recent figure standing at $14.9 million for Q4 2025.
- In Q4 2025, Leases rose 4.47% year-over-year to $14.9 million; the TTM figure through Dec 2025 stood at $14.9 million (up 4.47% YoY), while the FY2025 annual figure was $14.4 million, up 1.4% from the prior year.
- Leases came in at $14.9 million for Q4 2025 at Immatics, down from $16.0 million in the prior quarter.
- In the past five years, Leases ranged from a high of $16.4 million in Q1 2025 to a low of $7.6 million in Q1 2021.
- A 5-year average of $13.6 million and a median of $14.5 million in 2023 frame the typical range for Leases.
- Across the five-year window, Leases jumped 81.94% in 2022 and fell 7.53% in 2024, its largest moves.
- Immatics' Leases stood at $11.4 million in 2021, then advanced by 16.44% to $13.3 million in 2022, then climbed by 7.68% to $14.3 million in 2023, then declined by 0.5% to $14.2 million in 2024, then rose by 4.47% to $14.9 million in 2025.
- According to Business Quant data, Leases over the past three periods registered $14.9 million, $16.0 million, and $16.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Immatics | 1.80 Bn | 1.80 Bn | - | 14.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.88 Mn |
| Sep 30, 2025 | 16.02 Mn |
| Jun 30, 2025 | 16.37 Mn |
| Mar 31, 2025 | 16.39 Mn |
| Dec 31, 2024 | 14.25 Mn |
| Sep 30, 2024 | 14.64 Mn |
| Jun 30, 2024 | 15.74 Mn |
| Mar 31, 2024 | 12.91 Mn |
| Dec 31, 2023 | 14.32 Mn |
| Sep 30, 2023 | 15.57 Mn |
| Jun 30, 2023 | 16.06 Mn |
| Mar 31, 2023 | 13.96 Mn |
| Dec 31, 2022 | 13.30 Mn |
| Sep 30, 2022 | 14.81 Mn |
| Jun 30, 2022 | 16.02 Mn |
| Mar 31, 2022 | 10.43 Mn |
| Dec 31, 2021 | 11.42 Mn |
| Sep 30, 2021 | 8.59 Mn |
| Jun 30, 2021 | 8.81 Mn |
| Mar 31, 2021 | 7.58 Mn |
| Dec 31, 2020 | 7.33 Mn |
| Sep 30, 2020 | 7.96 Mn |
| Jun 30, 2020 | 8.25 Mn |
| Dec 31, 2019 | 3.64 Mn |